Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
News

Plan B emergency contraceptive may be ineffective for heavier women

Laura Eggertson
CMAJ January 07, 2014 186 (1) E21-E22; DOI: https://doi.org/10.1503/cmaj.109-4671
Laura Eggertson
CMAJ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

News that emergency contraceptive pills containing levonorgestrel may not prevent pregnancy in women who weigh 165 pounds or more is raising questions about the formulation’s initial clinical trials and the lag in making this information available to women.

The emergency contraceptive formulation of levonorgestrel, marketed as Plan B in Canada, has been approved for sale in Canada since February 2000 without warnings on its product monograph about the medication’s effectiveness relative to weight.

A 2011 meta-analysis concluded that women who take levonorgestrel for emergency contraception, and have a body mass index (BMI) that deems them obese, have a three times greater risk of pregnancy than women with a normal BMI (Contraception 2011;84:363–7).

Since then, HRA Pharma, the European manufacturer of the emergency contraceptive, has re-examined its data and is changing the labelling on its Norlevo brand of levonorgestrel to warn that it is less effective for women who weigh 165 pounds or more, regardless of BMI.

That is vital information that should have been made available to Health Canada — and to Canadian women — long before now, says Anne Rochon Ford, executive director of the Canadian Women’s Health Network.

“I’m really stunned that it’s been on the market for so long and we’re just finding out now,” says Rochon Ford. “Who were they studying it on in the clinical trials? It just raises so many red flags about how clinical trials are done.”

Many women weigh 165 pounds or more, which implies that the “morning-after” pill was not tested on a variety of body types, Rochon Ford suggests. In the United States, for example, 165 pounds is considered an average weight for women.

Figure

In Canada, the emergency contraceptive formulation of levonorgestrel is sold as Plan B and its labelling does not indicate that efficacy is related to body weight.

Image courtesy of Laura Eggertson

“This is a classic case of ‘You’re still a guinea pig when the drug is already out on the market,’” Rochon Ford adds.

In Canada, Teva Pharmaceuticals manufactures the emergency contraceptive formulation of levonorgestrel and sells it as Plan B, but the drug contains the same active ingredient at the same dosage as the European version.

That gives Canadian women cause for concern if they are considering using Plan B as emergency contraception but weigh 165 pounds or more, says Barbara Mintzes, an assistant professor in the University of British Columbia’s Department of Anesthesiology, Pharmacology and Therapeutics. “There’s no reason to think that the warnings in the European Union would be less applicable here,” says Mintzes. “It certainly begs the question about why, in countries where Plan B has been approved, there hasn’t been a review and a warning about use by women who are obese.”

Health Canada is aware of the label change in Europe, says Leslie Meerburg, a Health Canada media relations advisor. The regulator has not yet provided advice to Canadian women or health professionals on the matter. “Health Canada is assessing the available data on the effectiveness of this product, and will take appropriate action if required, such as working with the manufacturer to update the product labelling and notifying health care professionals and consumers of this change.”

The US Food and Drug (FDA) Administration is also reviewing the scientific information about the emergency contraceptive formulation of levonorgestrel, Erica Jefferson, FDA deputy director of media affairs, writes in an email. “The agency will then determine what, if any, labeling changes to approved emergency contraceptives are warranted.” The emergency contraceptive’s original product approval did not contain any specific assessment related to weight, Jefferson wrote.

Paladin Labs, which distributes Plan B in Canada, has not yet seen HRA Pharma’s initial data, and so cannot comment on it, says Patrice Larose, vice-president of scientific affairs for Paladin. “I’m sure that authorities that have the data will look at it, and if they think there are any labelling changes that are needed, we will discuss it.”

Companies are required to provide Health Canada and other regulators with periodic safety and efficacy updates, including any new information about their drug, says Mintzes. It’s also possible that there were some indications in early premarket trials that the morning-after pill was less effective for heavier women, says Mintzes. But the only way for consumers and health professionals to know what Health Canada knows is to make the data publicly available, she adds. “It’s another example of why we should have full public access to all of the effectiveness and safety data before a drug is marketed.”

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 186 (1)
CMAJ
Vol. 186, Issue 1
7 Jan 2014
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Plan B emergency contraceptive may be ineffective for heavier women
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Plan B emergency contraceptive may be ineffective for heavier women
Laura Eggertson
CMAJ Jan 2014, 186 (1) E21-E22; DOI: 10.1503/cmaj.109-4671

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Plan B emergency contraceptive may be ineffective for heavier women
Laura Eggertson
CMAJ Jan 2014, 186 (1) E21-E22; DOI: 10.1503/cmaj.109-4671
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Longer family medicine residency: Boon or bane to doctor supply?
  • The evolving picture of long COVID
  • When are shared decisions false choices?
Show more News

Similar Articles

Collections

  • Topics
    • Drugs: urogenital
    • Reproductive health, infertility & pregnancy

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2022, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire